WO1988001997A3 - Derives d'azaindole et d'indolizine, leur procede de production et leur utilisation comme produits pharmaceutiques - Google Patents
Derives d'azaindole et d'indolizine, leur procede de production et leur utilisation comme produits pharmaceutiques Download PDFInfo
- Publication number
- WO1988001997A3 WO1988001997A3 PCT/EP1987/000511 EP8700511W WO8801997A3 WO 1988001997 A3 WO1988001997 A3 WO 1988001997A3 EP 8700511 W EP8700511 W EP 8700511W WO 8801997 A3 WO8801997 A3 WO 8801997A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- compound
- processes
- azaindole
- pharmaceuticals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Composés de formule (I), dans laquelle: soit un Y est -N- et les autres sont -CH-; X est un composé de formule (II); X1 est un composé de formule (III), avec la formation de liaisons appropriées; R1 est un alkyle primaire ou secondaire, dépourvu d'atomes de carbone asymétriques; R2 est un phényle substitué ou non substitué, alkyle C1-6 primaire ou secondaire dépourvu d'atomes de carbone asymétriques, C3-6 cycloalkyle ou phénylalkyle, selon la définition donnée dans la description; A est comme a) un composé de formule (IV) ou (V), b) -(CH2)n-, où n est égal à 1, 2 ou 3; Z est a) un composé de formule (VI), un composé de formule (VII), où R8 est hydrogène, R9 ou M, R9 étant un groupe ester hydrolysable et physiologiquement compatible, et M étant un cation pharmaceutiquement acceptable; soit tous les Y sont -CH-, X est -N-, X1 est un composé de formule (VIII), avec la formation de liaisons appropriées; R1 et R2 ont indépendamment l'un de l'autre la définition de R2 donnée ci-dessus, R2 pouvant être en outre de l'hydrogène; A et Z ont la définition donnée ci-dessus. Ces composés sont produits en plusieurs étapes et sont utiles comme agents hypolipoprotéinémiques et anti-athéroscléreux.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU875259A HU200769B (en) | 1986-09-10 | 1987-09-09 | Process for producing azaindole and indolizine derivatives and pharmaceuticalo compositions comprising same as active ingredient |
FI882160A FI882160A0 (fi) | 1986-09-10 | 1988-05-09 | Azaindol- och indolizinderivat, foerfaranden foer deras framstaellning samt deras anvaendning som laekemedel. |
DK254488A DK254488A (da) | 1986-09-10 | 1988-05-09 | Azaindol- og indolizinderivater |
KR1019880700517A KR880701719A (ko) | 1986-09-10 | 1988-05-10 | 아자인돌 및 인돌리진 유도체, 이들의 제조방법 및 이들 약제로서의 용도 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90589786A | 1986-09-10 | 1986-09-10 | |
US905,897 | 1986-09-10 | ||
US06/945,750 US4751235A (en) | 1986-12-23 | 1986-12-23 | Anti-atherosclerotic indolizine derivatives |
US945,750 | 1986-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1988001997A2 WO1988001997A2 (fr) | 1988-03-24 |
WO1988001997A3 true WO1988001997A3 (fr) | 1988-04-07 |
Family
ID=27129444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1987/000511 WO1988001997A2 (fr) | 1986-09-10 | 1987-09-09 | Derives d'azaindole et d'indolizine, leur procede de production et leur utilisation comme produits pharmaceutiques |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0265640A3 (fr) |
JP (1) | JPH01500834A (fr) |
KR (1) | KR880701719A (fr) |
AU (1) | AU606621B2 (fr) |
DK (1) | DK254488A (fr) |
FI (1) | FI882160A0 (fr) |
HU (1) | HU200769B (fr) |
IL (1) | IL83821A0 (fr) |
NZ (1) | NZ221717A (fr) |
PL (1) | PL267646A1 (fr) |
PT (1) | PT85662B (fr) |
WO (1) | WO1988001997A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9345708B2 (en) | 2009-06-17 | 2016-05-24 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
US9394302B2 (en) | 2011-08-01 | 2016-07-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0352575A3 (fr) * | 1988-07-28 | 1991-08-21 | Bayer Ag | Pyrroles annelés substitués |
IL91941A (en) * | 1988-10-13 | 1994-10-21 | Sandoz Ag | Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a) |
JPH04270285A (ja) * | 1988-11-14 | 1992-09-25 | Nissan Chem Ind Ltd | ピラゾロピリミジン系メバロノラクトン類 |
US5025000A (en) * | 1990-03-02 | 1991-06-18 | E. R. Squibb & Sons, Inc. | Phosphorus-containing HMG-CoA reductase inhibitor compounds |
US5124453A (en) * | 1990-03-02 | 1992-06-23 | E. R. Squibb & Sons, Inc. | Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof |
WO1992019239A1 (fr) * | 1991-05-01 | 1992-11-12 | University Of New Mexico | Traitement d'etats cellulaires aberrants a l'aide de biomodulateurs |
WO1992019240A1 (fr) * | 1991-05-01 | 1992-11-12 | University Of New Mexico | Traitement d'aberrations cellulaires avec des biomodulateurs |
FR2687402B1 (fr) * | 1992-02-14 | 1995-06-30 | Lipha | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
EP1535922A4 (fr) | 2002-07-11 | 2006-10-04 | Takeda Pharmaceutical | Derive de pyrrolopyridine et utilisation de ce dernier |
TWI471133B (zh) | 2004-03-30 | 2015-02-01 | Vertex Pharma | 適合作為jak及其它蛋白質激酶抑制劑之氮雜吲哚 |
AU2007207533B8 (en) | 2006-01-17 | 2012-06-28 | Vertex Pharmaceuticals Incorporated | Azaindoles useful as inhibitors of Janus kinases |
KR20090091350A (ko) | 2006-12-21 | 2009-08-27 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제 억제제로 유용한 5-시아노-4-피롤로[2,3b]피리딘-3-일)-피리디민 유도체 |
CA2822057A1 (fr) | 2010-12-16 | 2012-06-21 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de la replication des virus de la grippe |
EP3578554A1 (fr) | 2013-11-13 | 2019-12-11 | Vertex Pharmaceuticals Incorporated | Inhibiteurs de la réplication des virus de la grippe |
LT3421468T (lt) | 2013-11-13 | 2021-01-11 | Vertex Pharmaceuticals Incorporated | Gripo virusų replikacijos inhibitorių paruošimo būdai |
EP3294717B1 (fr) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Procédés de préparation d'inhibiteurs de réplication des virus de la grippe |
MA42422A (fr) | 2015-05-13 | 2018-05-23 | Vertex Pharma | Inhibiteurs de la réplication des virus de la grippe |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2707048A1 (de) * | 1976-02-19 | 1977-09-01 | Labaz | Neue indolizinderivate, verfahren zu deren herstellung, sowie diese enthaltende zusammensetzungen |
EP0010951A1 (fr) * | 1978-10-30 | 1980-05-14 | Sankyo Company Limited | Dérivés de 4-hydroxy-2-pyrones, procédé pour leur préparation et leurs préparations pharmaceutiques |
EP0114027A1 (fr) * | 1982-11-22 | 1984-07-25 | Sandoz Ag | Analogues de la mévalolactone et dérivés, procédé pour les préparer, compositions pharmaceutiques les contenant et leur utilisation comme médicaments |
EP0117228A1 (fr) * | 1983-01-24 | 1984-08-29 | Sandoz Ag | Analogues de mévalonolactone et leur dérivés, leur procédé de production, compositions pharmaceutiques les contenant ainsi que leur utilisation comme médicaments |
US4474971A (en) * | 1982-09-29 | 1984-10-02 | Sandoz, Inc. | (Tetrahydropyran-2-yl)-aldehydes |
WO1986000307A2 (fr) * | 1984-06-22 | 1986-01-16 | Sandoz Ag | Analogues pyrazole de la mevalonolactone et leurs derives, leurs procedes de preparation et leur utilisation |
US4571428A (en) * | 1983-07-08 | 1986-02-18 | Sandoz, Inc. | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones |
WO1986007054A1 (fr) * | 1985-05-22 | 1986-12-04 | Sandoz Ag | Analogues d'imidazole de mevalonolactone et leurs derives |
US4677211A (en) * | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
-
1987
- 1987-09-08 NZ NZ221717A patent/NZ221717A/xx unknown
- 1987-09-08 IL IL83821A patent/IL83821A0/xx unknown
- 1987-09-08 PT PT85662A patent/PT85662B/pt not_active IP Right Cessation
- 1987-09-09 HU HU875259A patent/HU200769B/hu not_active IP Right Cessation
- 1987-09-09 PL PL1987267646A patent/PL267646A1/xx unknown
- 1987-09-09 EP EP87113159A patent/EP0265640A3/fr not_active Withdrawn
- 1987-09-09 AU AU80221/87A patent/AU606621B2/en not_active Expired - Fee Related
- 1987-09-09 WO PCT/EP1987/000511 patent/WO1988001997A2/fr active Application Filing
- 1987-09-09 JP JP62505829A patent/JPH01500834A/ja active Pending
-
1988
- 1988-05-09 FI FI882160A patent/FI882160A0/fi not_active Application Discontinuation
- 1988-05-09 DK DK254488A patent/DK254488A/da not_active Application Discontinuation
- 1988-05-10 KR KR1019880700517A patent/KR880701719A/ko not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2707048A1 (de) * | 1976-02-19 | 1977-09-01 | Labaz | Neue indolizinderivate, verfahren zu deren herstellung, sowie diese enthaltende zusammensetzungen |
EP0010951A1 (fr) * | 1978-10-30 | 1980-05-14 | Sankyo Company Limited | Dérivés de 4-hydroxy-2-pyrones, procédé pour leur préparation et leurs préparations pharmaceutiques |
US4474971A (en) * | 1982-09-29 | 1984-10-02 | Sandoz, Inc. | (Tetrahydropyran-2-yl)-aldehydes |
EP0114027A1 (fr) * | 1982-11-22 | 1984-07-25 | Sandoz Ag | Analogues de la mévalolactone et dérivés, procédé pour les préparer, compositions pharmaceutiques les contenant et leur utilisation comme médicaments |
EP0117228A1 (fr) * | 1983-01-24 | 1984-08-29 | Sandoz Ag | Analogues de mévalonolactone et leur dérivés, leur procédé de production, compositions pharmaceutiques les contenant ainsi que leur utilisation comme médicaments |
US4571428A (en) * | 1983-07-08 | 1986-02-18 | Sandoz, Inc. | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones |
WO1986000307A2 (fr) * | 1984-06-22 | 1986-01-16 | Sandoz Ag | Analogues pyrazole de la mevalonolactone et leurs derives, leurs procedes de preparation et leur utilisation |
US4677211A (en) * | 1984-06-29 | 1987-06-30 | Sandoz Pharmaceuticals Corp. | Preparation of lactones |
WO1986007054A1 (fr) * | 1985-05-22 | 1986-12-04 | Sandoz Ag | Analogues d'imidazole de mevalonolactone et leurs derives |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9345708B2 (en) | 2009-06-17 | 2016-05-24 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
US9518056B2 (en) | 2009-06-17 | 2016-12-13 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
US9394302B2 (en) | 2011-08-01 | 2016-07-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
Also Published As
Publication number | Publication date |
---|---|
HU200769B (en) | 1990-08-28 |
PT85662A (en) | 1987-10-01 |
EP0265640A2 (fr) | 1988-05-04 |
KR880701719A (ko) | 1988-11-04 |
PT85662B (pt) | 1990-06-29 |
IL83821A0 (en) | 1988-02-29 |
JPH01500834A (ja) | 1989-03-23 |
HUT46914A (en) | 1988-12-28 |
FI882160A (fi) | 1988-05-09 |
FI882160A0 (fi) | 1988-05-09 |
PL267646A1 (en) | 1988-07-21 |
NZ221717A (en) | 1990-08-28 |
EP0265640A3 (fr) | 1988-05-18 |
AU606621B2 (en) | 1991-02-14 |
AU8022187A (en) | 1988-04-07 |
DK254488D0 (da) | 1988-05-09 |
WO1988001997A2 (fr) | 1988-03-24 |
DK254488A (da) | 1988-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1988001997A3 (fr) | Derives d'azaindole et d'indolizine, leur procede de production et leur utilisation comme produits pharmaceutiques | |
BG60262B2 (en) | Process for the preparation of substituted bicyclic compounds | |
CA2187024A1 (fr) | Hydroxyesters de rapamicyne, leur procede d'obtention et preparations pharmaceutiques les contenant | |
UA8022A1 (uk) | Спосіб одержання похідних бензімідазолу у вигляді суміші ізомерів або індивідуальних ізомерів у вільному вигляді або у вигляді їх фізіологічно прийнятих солей | |
AU4321397A (en) | Pyrazolopyridylpyridazinone derivatives and process for preparing the same | |
CA2175372A1 (fr) | Nouveaux derives du 9-hydroxy-pyrido[1,2-a]pyrimidine-4-one ether | |
DE29724281U1 (de) | 4-Phenylpiperidin-Verbindungen | |
WO2003010142A3 (fr) | Procede | |
GEP19960641B (en) | Process for production of [3h]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one derivatives | |
CA2196900A1 (fr) | Analogues de 2-nitro-imidazole fluores pour la detection des cellules tumorales hypoxiques | |
HUT49889A (en) | Process for producing acyl derivatives | |
EP0314280A3 (en) | Process for the preparation of fused pyridine compounds | |
EP1186604A4 (fr) | Derives de benzazepine, procede de preparation de ces derives et utilisation | |
DE69129165D1 (de) | Prozess zur Darstellung von Lactamderivaten | |
ATE110724T1 (de) | Herstellung von 1,4-diazabicyclo(3.2.2>nonanen. | |
CA2033937A1 (fr) | Hemihydrate | |
JPS6442472A (en) | Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient | |
CA2293672A1 (fr) | Derives tricycliques de ceto-amides s'utilisant comme inhibiteurs de la transferase de proteine de farnesyl | |
EP0253891A4 (fr) | Composes aromatiques de bismaleimido et procede de preparation. | |
EP1092720A3 (fr) | Procédé pour la préparation de 3-pyridylsulphonylpyrazolo[4,3-d]pyrimidin-7-ones et intermédiaires | |
EP0080570A3 (en) | Ailanthone derivatives | |
IE820239L (en) | Carbapenem derivatives | |
DK443587D0 (da) | Fremgangsmaade til fremstilling af substituerede indolinonderivater | |
JPS5772981A (en) | 1,8-naphthyridine derivative and its salt | |
EP0592669A4 (en) | Optically active trifluorolactic acid derivative and liquid crystal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU DK FI HU JP KR |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU DK FI HU JP KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 882160 Country of ref document: FI |